Hemophilia A in a Male Parson Russell Terrier Puppy.

Autor: Aroch, I.¹ itamar.aroch@mail.huji.ac.il, Tamarin, I.², Kuzi, S.¹

Publikováno v: Israel Journal of Veterinary Medicine. Dec2015, Vol. 70 Issue 4, p57-62. 6p.

Rivaroxaban treatment among children with cancer-associated thromboembolism: Real-world data.

Autor: Barg AA; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; National Hemophilia Center, Thrombosis Unit and Amalia Biron Research Institute of Thrombosis and Hemostasis, Sheba Medical Center, Tel Hashomer, Israel.; Department of Pediatric Hematology, Oncology & BMT, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel., Levy-Mendelovich S; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; National Hemophilia Center, Thrombosis Unit and Amalia Biron Research Institute of Thrombosis and Hemostasis, Sheba Medical Center, Tel Hashomer, Israel.; Sheba Talpiot Medical Leadership Program., Gilad O; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Department of Pediatric Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel., Yacobovich J; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Department of Pediatric Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel., Tamarin I; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; National Hemophilia Center, Thrombosis Unit and Amalia Biron Research Institute of Thrombosis and Hemostasis, Sheba Medical Center, Tel Hashomer, Israel.; The Dworman Automated-Mega Laboratory, Sheba Medical Center, Tel-Hashomer, Israel., Budnik I; Department of Pathophysiology, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia., Golan H; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Department of Pediatric Hematology, Oncology & BMT, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel., Toren A; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Department of Pediatric Hematology, Oncology & BMT, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel., Kenet G; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; National Hemophilia Center, Thrombosis Unit and Amalia Biron Research Institute of Thrombosis and Hemostasis, Sheba Medical Center, Tel Hashomer, Israel.

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2022 Oct; Vol. 69 (10), pp. e29888. Date of Electronic Publication: 2022 Jul 20.

Factor XIII mediates adhesion of platelets to endothelial cells through α vβ 3 and glycoprotein IIb/IIIa integrins

Autor: Dardik, R., Shenkman, B., Tamarin, I., Eskaraev, R., Harsfalvi, J., Varon, D., Inbal, A. ^*

Publikováno v: In Thrombosis Research 2002 105(4):317-323

The potential role of emicizumab prophylaxis in severe von Willebrand disease.

Autor: Barg AA; National Hemophilia Center, Sheba Medical center, Tel Hashomer, Israel; Amalia Biron Research Institute of Thrombosis and Hemostasis, Sackler School of Medicine, Tel Aviv University, Israel., Avishai E; National Hemophilia Center, Sheba Medical center, Tel Hashomer, Israel; Amalia Biron Research Institute of Thrombosis and Hemostasis, Sackler School of Medicine, Tel Aviv University, Israel., Budnik I; Department of Pathophysiology, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia., Brutman TB; National Hemophilia Center, Sheba Medical center, Tel Hashomer, Israel; Amalia Biron Research Institute of Thrombosis and Hemostasis, Sackler School of Medicine, Tel Aviv University, Israel., Tamarin I; National Hemophilia Center, Sheba Medical center, Tel Hashomer, Israel., Dardik R; National Hemophilia Center, Sheba Medical center, Tel Hashomer, Israel., Bashari D; National Hemophilia Center, Sheba Medical center, Tel Hashomer, Israel., Misgav M; National Hemophilia Center, Sheba Medical center, Tel Hashomer, Israel., Lubetsky A; National Hemophilia Center, Sheba Medical center, Tel Hashomer, Israel., Lalezari S; National Hemophilia Center, Sheba Medical center, Tel Hashomer, Israel., Livnat T; National Hemophilia Center, Sheba Medical center, Tel Hashomer, Israel; Amalia Biron Research Institute of Thrombosis and Hemostasis, Sackler School of Medicine, Tel Aviv University, Israel., Kenet G; National Hemophilia Center, Sheba Medical center, Tel Hashomer, Israel; Amalia Biron Research Institute of Thrombosis and Hemostasis, Sackler School of Medicine, Tel Aviv University, Israel. Electronic address: gili.kenet@sheba.health.gov.il.

Publikováno v: Blood cells, molecules & diseases [Blood Cells Mol Dis] 2021 Mar; Vol. 87, pp. 102530. Date of Electronic Publication: 2020 Dec 08.

Debates Surrounding the Use of Antithrombotic Therapy in Hemophilic Patients with Cardiovascular Disease: Best Strategies to Minimize Severe Bleeding Risk.

Autor: Badulescu, Oana-Viola¹ (AUTHOR) oana.badulescu@umfiasi.ro, Scripcariu, Dragos Viorel² (AUTHOR) dragos-viorel.scripcariu@umfiasi.ro, Badescu, Minerva Codruta³ (AUTHOR), Ciocoiu, Manuela¹ (AUTHOR) dragos-viorel.scripcariu@umfiasi.ro, Vladeanu, Maria Cristina¹ (AUTHOR), Plesoianu, Carmen Elena³ (AUTHOR), Bojan, Andrei² (AUTHOR), Iliescu-Halitchi, Dan³ (AUTHOR), Tudor, Razvan² (AUTHOR), Huzum, Bogdan² (AUTHOR), Bararu Bojan, Iris¹ (AUTHOR)

Publikováno v: International Journal of Molecular Sciences. Jul2024, Vol. 25 Issue 14, p7845. 17p.